首页> 外国专利> USE OF HUMAN CB2 RECEPTOR AGONISTIC COMPOUNDS FOR THE PREPARATION OF IMMUNOMODULATORY DRUGS, NOVEL AGONIST COMPOUNDS OF CB2 RECEPTOR AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

USE OF HUMAN CB2 RECEPTOR AGONISTIC COMPOUNDS FOR THE PREPARATION OF IMMUNOMODULATORY DRUGS, NOVEL AGONIST COMPOUNDS OF CB2 RECEPTOR AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

机译:使用人类CB2受体农残化合物制备免疫调节药物,CB2受体新型激动剂化合物以及包含相同成分的药物组合物

摘要

The use of human CB2 receptor-specific agonists of formula (I) or (I') for preparing immunomodulating drugs is disclosed. In formulae (I) and (I'), R1 is a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11, -CHR9CH2NR'6R'11, -(CH2)nZ and -COR8; R'1 is a -CH2CHR10NR6R11 or -(CH2)2NR'6R'11 group; R2 and R'2 are hydrogen, halogen or C1-4 alkyl; R3 is hydrogen, C1-4 alkyl or a group selected from -CH2CHR10NR6R11, -(CH2)2NR'6R'11 and -COR8; R'3 is a =CR6R8 group; R4 has one of the meanings given for R5 or is a -COR8 group; R5 is hydrogen, C1-4 alkyl, C1-4 alkoxy, a halogen atom, a CF3 group, an OCF3 group or C1-4 alkylthio; R'5 has one of the meanings given for R5 and is in the 5 or 6 position of the indene ring; R6 is hydrogen or C1-4 alkyl; R'6 is C1-4 alkyl; R7 has one of the meanings given for R5 or R7 and R9 together form a -Y-CH2- group attached to the indole ring in the 7 position by a group Y; R8 is phenyl substituted one to four times by a substituent selected from halogen, C1-4 alkyl or C1-4 alkoxy; a polycyclic ring selected from naphth-1-yl, naphth-2-yl, 1,2,3,4-tetrahydronaphth-1-yl, 1,2,3,4-tetrahydronaphth-5-yl, anthryl, benzofuryl, benzothien-2-yl, benzothien-3-yl, 2-, 3-, 4- or 8-quinolyl, said polycyclic rings optionally being substituted once or twice by a substituent selected from C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halogen, cyano, hydroxyl, trifluoromethyl and imidazol-1-yl; R10 and R11 together are a group selected from -CH2-O-CH2-CR12R13- and -(CH2)p-CR12R13-, wherein the carbon atom substituted by R12 and R13 is attached to the nitrogen atom; R'11 is C1-4 alkyl; or R'11 and R'6, taken together with the nitrogen atom to which they are attached, form a group selected from morpholin-4-yl, thiomorpholin-4-yl, piperidin-1-yl and pyrolidin-1-yl; each of R12 and R13 is independently hydrogen or C1-4 alkyl; n is 2, 3, 4 or 5; p is 2 or 3; Z is a methyl group or a halogen atom; and Y is a methylene group or an oxygen atom.
机译:公开了式(I)或(I')的人CB 2受体特异性激动剂在制备免疫调节药物中的用途。在式(I)和(I′)中,R 1为选自-CH 2 CHR 10NR 6 R 11,-(CH 2)2NR′6R′11,-CHR 9 CH 2 NR′6R′11,-(CH 2)n Z和-COR 8的基团。 R'1是-CH2CHR10NR6R11或-(CH2)2NR'6R'11基团; R2和R'2是氢,卤素或C1-4烷基; R3是氢,C1-4烷基或选自-CH2CHR10NR6R11,-(CH2)2NR'6R'11和-COR8的基团; R'3是= CR6R8基团; R4具有对于R5给出的含义之一或为-COR8基团; R5是氢,C1-4烷基,C1-4烷氧基,卤素原子,CF3基,OCF3基或C1-4烷硫基; R′5具有R5所给出的含义之一,并且在茚环的5或6位。 R6是氢或C1-4烷基; R'6为C1-4烷基; R7具有R5所给出的含义之一,或R7和R9一起形成-Y-CH2-基团,该基团通过基团Y连接在7位的吲哚环上; R8是被选自卤素,C1-4烷基或C1-4烷氧基的取代基取代1-4倍的苯基;选自萘-1-基,萘-2-基,1,2,3,4-四氢萘-1-基,1,2,3,4-四氢萘-5-基,蒽基,苯并呋喃基,苯并噻吩的多环-2-基,苯并噻吩-3-基,2-,3-,4-或8-喹啉基,所述多环任选地被选自C 1-4烷基,C 1-4烷氧基,C 1-的取代基取代一次或两次。 4烷硫基,卤素,氰基,羟基,三氟甲基和咪唑-1-基; R10和R11一起是选自-CH2-O-CH2-CR12R13-和-(CH2)p-CR12R13-的基团,其中被R12和R13取代的碳原子连接在氮原子上; R'11是C1-4烷基; R'11和R'6与它们所连接的氮原子一起形成选自吗啉-4-基,硫吗啉-4-基,哌啶-1-基和吡咯烷-1-基的基团;或R12和R13各自独立地为氢或C1-4烷基。 n为2、3、4或5; p是2或3; Z为甲基或卤原子; Y为亚甲基或氧原子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号